Results 21 to 30 of about 8,292 (213)

Estrés y Enfermedad de Crohn: diferencias entre enfermos de Crohn con brote, sin brote y personas sanas [PDF]

, 2012
Distintas investigaciones han puesto de manifiesto la relación entre estrés y numerosas patologías. Este estudio pretende explorar su relación con la enfermedad de Crohn. Se compararon los niveles de estrés, medidos mediante la escala de estrés percibido,
Arias Astray, Andrés, Barrón López de Roda, Ana, Briaschi Diaferia, Lorenzo, Dios Duarte, María José de   +3 more
core   +1 more source

Multimodal Integration of Protein Interactomes With Genomic and Molecular Data Discovers Distinct Rheumatoid Arthritis Endotypes

Arthritis &Rheumatology, EarlyView.
Objective Rheumatoid arthritis (RA) is a heterogeneous autoimmune disease characterized by clinical and molecular heterogeneity, notably in the presence of anti–cyclic citrullinated peptide (CCP) antibodies. Patients with CCP+ RA exhibit more severe disease progression and distinct treatment responses compared to patients with CCP− RA.
Javad Rahimikollu, Priyamvada Guha Roy, Akash Kishore, Danica Morgan Lee, Lauren A. Vanderlinden, Kiran Nazarali, Fan Zhang, Dana P. Ascherman, Daniella M. Schwartz, Larry Moreland, Jishnu Das   +10 more
wiley   +1 more source

Una malaltia intestinal amb riscos emocionals [PDF]

, 2007
La malaltia de Crohn provoca l'aparició d'úlceres als budells prim i gruixut. Els símptomes que comporta, els efectes secundaris dels fàrmacs i les complicacions potencials de la malaltia contribueixen a un empitjorament psicosocial i emocional que pot ...
Gallardo, Olga, Universitat Autònoma de Barcelona   +1 more
core   +1 more source

Transfusion‐related alpha‐gal syndrome: Two new cases expanding the demographic and geographic spectrum, and evidence of a diagnostic gap in allergic transfusion reaction evaluation

Transfusion, EarlyView.
Abstract Background Transfusion‐related alpha‐gal syndrome (TRAGS) has recently been proposed as a cause of allergic transfusion reactions (ATRs) in which alpha‐gal‐specific IgE in sensitized group O (or potentially group A) recipients reacts with epitopes on group B or AB plasma‐containing components.
Mackenzie Foster, Miriam Brown, Angela Mueller, Toufik Tahiri, Kaycie Atchison, Deva Sharma, Cosby A. Stone Jr., Jonathan Tucci, Garrett S. Booth, Jeremy W. Jacobs   +9 more
wiley   +1 more source

Computational fluid dynamics study of the intestinal stenosis caused by Crohn’s disease [PDF]

, 2017
La enfermedad de Crohn es una enfermedad crónica que causa la inflamación de cualquier parte del sistema gastrointestinal, producido por el ataque al sistema inmunitario.
Abril-López, Eduardo
core  

Real‐World Effectiveness and Safety of Upadacitinib in Crohn's Disease: Insights From the Eneida Registry

United European Gastroenterology Journal, Volume 14, Issue 4, May 2026.
ABSTRACT Background Upadacitinib (UPA) is the first oral Janus kinase (JAK) inhibitor approved for the treatment of Crohn's disease (CD). Real‐world data, particularly from large nationwide cohorts, remain limited. This study aimed to evaluate the real‐world effectiveness, safety, and treatment persistence of UPA in patients with CD.
M. Iborra, B. Botella, M. D. Martín‐Arranz, D. Ceballos, C. Martínez‐Pascual, A. Garrido, P. Varela, M. Moreta, E. Brunet‐Mas, Y. González‐Lama, E. Rodríguez‐González, M. Vicuña, J. P. Gisbert, I. Ordás, F. Argüelles‐Arias, J. Tosca‐Cuquerella, R. Vicente‐Lidón, M. Sierra‐Ausín, I. Rodríguez‐Lago, D. Martín‐Rodríguez, J. M. Paredes, B. Sicilia, I. García de la Filia, N. Jiménez, M. Barreiro‐de Acosta, E. Betoré, I. Ferrer‐Bradley, L. García‐Alles, J. M. Huguet, S. Castellet‐Farrús, M. J. García, A. Gutiérrez‐Casbas, Á. Ponferrada‐Díaz, L. Ramos, M. Calafat, I. Vera, C. Suárez‐Ferrer, E. Fernández‐Velado, S. Rodríguez‐Sánchez, A. Mínguez, A. Mancebo, J. Barrio, S. Lario, D. R. de La Cruz, Alejandro Hernández‐Camba, C. Rodríguez‐Gutiérrez, M. Chaparro, E. Ricart, L. Almenara‐Michelena, A. Balaguer, E. Domènech, P. Nos   +51 more
wiley   +1 more source

Diagnosis and treatment of inflammatory bowel disease: First Latin American Consensus of the Pan American Crohn's and Colitis Organisation

Revista de Gastroenterología de México (English Edition), 2017
The incidence and prevalence of inflammatory bowel disease (IBD) has increased in recent years in several Latin American countries. There is a need to raise awareness in gastroenterologists and the population in general, so that early diagnosis and ...
J.K. Yamamoto-Furusho, F. Bosques-Padilla, J. de-Paula, M.T. Galiano, P. Ibañez, F. Juliao, P.G. Kotze, J.L. Rocha, F. Steinwurz, G. Veitia, C. Zaltman   +10 more
doaj   +1 more source

Terapéutica biológica en la enfermedad de Crohn y en la colitis ulcerosa [PDF]

, 2008
Inclou referències ...
Dolz, Carlos
core  

Enfermedad de Crohn [PDF]

, 2014
La Enfermedad de Crohn y la Colitis Ulcerosa son unas enfermedades inflamatorias intestinales consideradas raras cuyos patrones epidemiológicos y clínicos fueron estudiados por REpIER hace varios años. Asturias, en esos estudios, presenta una elevada frecuencia de enfermedades inflamatorias intestinales crónicas medida en términos de Razón de ...
Vega, Paula, Margolles, Pedro, Mérida, Sara   +2 more
openaire   +1 more source

Temporal Trends in and Associations With Nonsteroidal Anti‐inflammatory Drug Prescription in Adult and Pediatric Patients With Inflammatory Bowel Disease

Arthritis Care &Research, Volume 78, Issue 4, Page 439-448, April 2026.
Objective Recent inflammatory bowel disease (IBD) treatment guidelines have recommended against nonsteroidal anti‐inflammatory drug (NSAID) use despite prevalent musculoskeletal symptoms and opioid overuse in this population. Given the discordance between changing national guidelines and potential clinical utility, we sought to assess national temporal
Adam S. Mayer, Rui Xiao, Andrew Grossman, Meenakshi Bewtra, Michael D. George, Pamela F. Weiss   +5 more
wiley   +1 more source